\-\ Texto\\:\\ \ \(0\)\
\-\ na\ \(21935\)\
\-\ radiation\\ and\\ intrathecal\\ chemotherapy\\.\ \(0\)\
\-\ \\ diffuse\\ enhancement\\ throughout\\ leptomeninges\\ of\\ the\\ posterior\\ fossa\\.\ \(0\)\
\-\ \\ enhancement\\ and\\ thickening\\ of\\ the\\ nerve\\ roots\\ of\\ the\\ cauda\\ equina\\.\ \(1\)\
\-\ lymphomatous\\ meningitis\ \(0\)\
\-\ guillain\\-barre\\?\\ syndrome\ \(0\)\
\-\ chronic\\ inflammatory\\ demyelinating\\ polyneuropathy\\,\\ sarcoidosis\ \(1\)\
\-\ lymphoma\ \(373\)\
\-\ meningeal\\ carcinomatosis\ \(5\)\
\-\ aids\\-related\\ cytomegalovirus\ \(0\)\
\-\ polyradiculopathy\\ \ \(1\)\
\-\ neuroborreliosis\\ \ \(1\)\
\-\ arachnoiditis\ \(3\)\
\-\ transverse\\ myelitis\ \(14\)\
\-\ spinal\\ cord\\ infarcts\ \(1\)\
\-\ lumbosacral\\ compression\\ from\\ disk\\ herniation\\ or\\ stenosis\ \(1\)\
\-\ the\\ patient\\ presents\\ with\\ a\\ history\\ of\\ intracranial\\ lymphoma\\,\\ initially\\ diagnosed\\ as\\ follicular\\ lymphoma\\,\\ now\\ diagnosed\\ by\\ the\\ nih\\ as\\ diffuse\\ large\\ b\\-cell\\ lymphoma\\ and\\ history\\ of\\ stage\\ i\\ grade\\ iii\\ follicular\\ lymphoma\\ of\\ the\\ axilla\\.\\ presents\\ this\\ admission\\ with\\ new\\ onset\\ of\\ lower\\ extremity\\ weakness\\ and\\ instability\\ for\\ the\\ last\\ 7\\-10\\ days\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lymphoma\\:\\ 0\\.10436746300809768\ \(0\)\
\-\ follicular\\:\\ 0\\.09636691613023167\ \(0\)\
\-\ lymphomatous\\:\\ 0\\.07534631131595299\ \(0\)\
\-\ aids\\-related\\:\\ 0\\.07534631131595299\ \(0\)\
\-\ neuroborreliosis\\:\\ 0\\.07534631131595299\ \(0\)\
\-\ polyradiculopathy\\:\\ 0\\.06942197643937226\ \(0\)\
\-\ guillain\\-barre\\:\\ 0\\.06595646269485803\ \(0\)\
\-\ arachnoiditis\\:\\ 0\\.06159043172249913\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.057573306686210794\ \(0\)\
\-\ 7\\-10\\:\\ 0\\.056566614073763066\ \(0\)\
\-\ intrathecal\\:\\ 0\\.0556660968459184\ \(0\)\
\-\ cytomegalovirus\\:\\ 0\\.0556660968459184\ \(0\)\
\-\ nih\\:\\ 0\\.0556660968459184\ \(0\)\
\-\ diagnosed\\:\\ 0\\.05371273772299155\ \(0\)\
\-\ myelitis\\:\\ 0\\.05113081264880583\ \(0\)\
\-\ axilla\\:\\ 0\\.05113081264880583\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.050642279197182345\ \(0\)\
\-\ cauda\\:\\ 0\\.048927145047933183\ \(0\)\
\-\ equina\\:\\ 0\\.048927145047933183\ \(0\)\
\-\ meningeal\\:\\ 0\\.04656600507675234\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.04546163130341896\ \(0\)\
\-\ demyelinating\\:\\ 0\\.045206477772225105\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.04471794432060162\ \(0\)\
\-\ diffuse\\:\\ 0\\.044222349066244705\ \(0\)\
\-\ roots\\:\\ 0\\.04340041714259085\ \(0\)\
\-\ lumbosacral\\:\\ 0\\.04340041714259085\ \(0\)\
\-\ disk\\:\\ 0\\.03953729642683823\ \(0\)\
\-\ na\\:\\ 0\\.03940876756047464\ \(0\)\
\-\ infarcts\\:\\ 0\\.03928214289564438\ \(0\)\
\-\ enhancement\\:\\ 0\\.039153654121761305\ \(0\)\
\-\ meningitis\\:\\ 0\\.03789309221617621\ \(0\)\
\-\ instability\\:\\ 0\\.03757844287324701\ \(0\)\
\-\ iii\\:\\ 0\\.0342863023866089\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.03298881509713879\ \(0\)\
\-\ herniation\\:\\ 0\\.032520368631369596\ \(0\)\
\-\ admission\\:\\ 0\\.03218514886082873\ \(0\)\
\-\ \\-\\:\\ 0\\.031311597584758356\ \(0\)\
\-\ last\\:\\ 0\\.031202841453358842\ \(0\)\
\-\ stage\\:\\ 0\\.031154140418191\ \(0\)\
\-\ intracranial\\:\\ 0\\.030867621682817974\ \(0\)\
\-\ i\\:\\ 0\\.03019072389084197\ \(0\)\
\-\ presents\\:\\ 0\\.029840073427485916\ \(0\)\
\-\ fossa\\:\\ 0\\.029767518211120763\ \(0\)\
\-\ initially\\:\\ 0\\.029726327728762224\ \(0\)\
\-\ transverse\\:\\ 0\\.02928586918076921\ \(0\)\
\-\ stenosis\\:\\ 0\\.02861075455411425\ \(0\)\
\-\ \\?\\:\\ 0\\.028503243595081256\ \(0\)\
\-\ grade\\:\\ 0\\.027819117888469833\ \(0\)\
\-\ cord\\:\\ 0\\.027753623249618817\ \(0\)\
\-\ throughout\\:\\ 0\\.027339720737606214\ \(0\)\
\-\ compression\\:\\ 0\\.027339720737606214\ \(0\)\
\-\ weakness\\:\\ 0\\.027124883359216964\ \(0\)\
\-\ extremity\\:\\ 0\\.026710760424294343\ \(0\)\
\-\ nerve\\:\\ 0\\.02631577885886587\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02617902380462278\ \(0\)\
\-\ spinal\\:\\ 0\\.026151933422047746\ \(0\)\
\-\ new\\:\\ 0\\.025451179288893663\ \(0\)\
\-\ inflammatory\\:\\ 0\\.025327486702495933\ \(0\)\
\-\ now\\:\\ 0\\.024966799911979896\ \(0\)\
\-\ thickening\\:\\ 0\\.024757474954644035\ \(0\)\
\-\ radiation\\:\\ 0\\.02396795939796869\ \(0\)\
\-\ onset\\:\\ 0\\.023054882272864532\ \(0\)\
\-\ days\\:\\ 0\\.022385250394632288\ \(0\)\
\-\ as\\:\\ 0\\.022095341981096205\ \(0\)\
\-\ syndrome\\:\\ 0\\.020888090399441384\ \(0\)\
\-\ chronic\\:\\ 0\\.020572560965017094\ \(0\)\
\-\ history\\:\\ 0\\.02017460748217237\ \(0\)\
\-\ posterior\\:\\ 0\\.01683451751027734\ \(0\)\
\-\ lower\\:\\ 0\\.016426171533024468\ \(0\)\
\-\ large\\:\\ 0\\.015970448135308374\ \(0\)\
\-\ by\\:\\ 0\\.012161289771323717\ \(0\)\
\-\ from\\:\\ 0\\.010824236864565918\ \(0\)\
\-\ or\\:\\ 0\\.008560023495416305\ \(0\)\
\-\ the\\:\\ 0\\.008271324725857954\ \(0\)\
\-\ this\\:\\ 0\\.008214847977043874\ \(0\)\
\-\ patient\\:\\ 0\\.007321298554840924\ \(0\)\
\-\ of\\:\\ 0\\.006970312868255718\ \(0\)\
\-\ \\,\\:\\ 0\\.006941283731212496\ \(0\)\
\-\ for\\:\\ 0\\.006231693578142865\ \(0\)\
\-\ and\\:\\ 0\\.0061541540421271275\ \(0\)\
\-\ a\\:\\ 0\\.003389741895885481\ \(0\)\
\-\ with\\:\\ 0\\.0020000713861519615\ \(0\)\
\-\ \\.\\:\\ 0\\.0015170741921942852\ \(0\)\
